Breast

Article	Citations
Current and future burden of breast cancer: Global statistics for 2020 and 2040	616
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic	160
The requirements of a specialist breast centre	104
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer	85
Global guidelines for breast cancer screening: A systematic review	71
Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer – A randomized controlled trial	63
Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)	57
Epidemiology of male breast cancer	53
Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review	51
Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation	48
Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis	46
Global challenges in breast cancer detection and treatment	42
Using artificial intelligence to analyse and teach communication in healthcare	42
The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis	42
Dissecting the biological heterogeneity of HER2-positive breast cancer	42
Effects of the COVID-19 pandemic on breast cancer screening in Taiwan	41
Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis	39
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance	38
A systematic review and meta-analysis of clinician-reported versus patient-reported outcomes of radiation dermatitis	38
The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis	34
Breast cancer surgery with augmented reality	33
Occult breast cancer: Where are we at?	32
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy	32
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data fr	32
Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening	29

Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer	29
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)	29
The emerging role of BET inhibitors in breast cancer	29
Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis	28
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis	27
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer	27
Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis	27
A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction	27
Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice	25
Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era	25
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D	25
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort	25
Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis	25
Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study	25
Comparison of complications according to incision types in nipple-sparing mastectomy and immediate reconstruction	24
A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges	24
The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy	24
Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability	23
Associations between absolute neutrophil count and lymphocyte-predominant breast cancer	23
A video-game based cognitive training for breast cancer survivors with cognitive impairment: A prospective randomized pilot trial	23
A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer	23
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective	22
Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,5	22
De-escalating axillary surgery in early-stage breast cancer	22
Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL	22
Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis	22
Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis	21
Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis	21
Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution’s Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer	20
“The emerging role of capivasertib in breast cancer”	20
Psychoeducation for breast cancer: A systematic review and meta-analysis	20
Potential immune response to breast implants after immunization with COVID-19 vaccines	20
Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy	20
Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder	20
Breast-related and body-related quality of life following autologous breast reconstruction is superior to implant-based breast reconstruction - A long-term follow-up study	19
A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis	19
Effect of multidisciplinary team care on the risk of recurrence in breast cancer patients: A national matched cohort study	19
Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis	19
Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics	18
Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study	18
Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis	18
Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto	18
Improving breast cancer care coordination and symptom management by using AI driven predictive toolkits	18
Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study	18
Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials	17
Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled B	17
Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer	17
Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer	17
The role of CDK4/6 inhibitors in early breast cancer	16
Tired of feeling tired – The role of circulating inflammatory biomarkers and long-term cancer related fatigue in breast cancer survivors	16

Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India	16
Pathways to breast cancer screening artificial intelligence algorithm validation	16
Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer	16
Machine learning to predict individual patient-reported outcomes at 2-year follow-up for women undergoing cancer-related mastectomy and breast reconstruction (INSPiRED-001)	16
Pathology after neoadjuvant treatment – How to assess residual disease	16
Positive effects of the enhanced recovery after surgery (ERAS) protocol in DIEP flap breast reconstruction	16
A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland	16
Preoperative non-palpable breast lesion localization, innovative techniques and clinical outcomes in surgical practice: A systematic review and meta-analysis	16
Interstitial lung disease in patients treated with Cyclin-Dependent Kinase 4/6 inhibitors: A systematic review and meta-analysis of randomized controlled trials	16
Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations	16
Calorie restriction and synbiotics effect on quality of life and edema reduction in breast cancer-related lymphedema, a clinical trial	16
Immediate Breast Reconstruction after mastectomy with polyurethane implants versus textured implants: A retrospective study with focus on capsular contracture	16
Population-based mammography screening attendance in Sweden 2017–2018: A cross-sectional register study to assess the impact of sociodemographic factors	16
Impact of body mass index on overall survival in patients with metastatic breast cancer	16
Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies	15
Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer	15
Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer	15
Breast cancer screening using synthesized two-dimensional mammography: A systematic review and meta-analysis	15
Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients	14
Adverse health effects after breast cancer up to 14 years after diagnosis	14
“This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients”	14
Phyllodes tumors of the breast: Adjuvant radiation therapy revisited	14
Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer	14
Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG	14
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective	14
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors	14
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study	14
A randomized study of olanzapine-containing versus standard antiemetic regimens for the prevention of chemotherapy-induced nausea and vomiting in Chinese breast cancer patients	14
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial	14
Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden	14
Prevalence of symptomatic dry eye in breast cancer patients undergoing systemic adjuvant treatment: A cross-sectional study	14
Axillary surgery in node-positive breast cancer	14
Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials	13
Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis	13
Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup – the “ATRESS” phenomenon	13
Clinical characteristics and survival outcome of patients with estrogen receptor low positive breast cancer	13
Predictive and prognostic values of tumor infiltrating lymphocytes in breast cancers treated with neoadjuvant chemotherapy: A meta-analysis	13
Evaluation of the 8th edition of the American joint committee on cancer’s pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastect	13
Mammographic density and prognosis in primary breast cancer patients	13
Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial	13
Is breast conservation superior to mastectomy in early stage triple negative breast cancer?	13
Radiological audit of interval breast cancers: Estimation of tumour growth rates	13
Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastati	13
Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study	13
Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis	13
On top of that all, now Covid-19, too. A scoping review of specificities and correlates of fear of cancer recurrence in breast cancer patients during COVID-19	12
Teaching cross-cultural design thinking for healthcare	12
NT-proBNP as predictor factor of cardiotoxicity during trastuzumab treatment in breast cancer patients	12
Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?	12
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up	12
“Three-dimensional evaluation of breast volume changes following autologous free flap breast reconstruction over six months”	12
Omission of axillary sentinel lymph node biopsy in early invasive breast cancer	12
Quality indicators for breast cancer care: A systematic review	12
Immediate direct-to-implant breast reconstruction with acellular dermal matrix: Evaluation of complications and safety	12
Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: Subgroup analysis of the p	12
Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis	12
Automatic detection of perforators for microsurgical reconstruction	12
Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers	12
Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study	12
Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer	12
A multidisciplinary approach to optimizing care of patients treated with alpelisib	12
Low neighborhood socioeconomic status is associated with higher mortality and increased surgery utilization among metastatic breast cancer patients	12
Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty?	11
Breast cancer risk, worry, and anxiety: Effect on patient perceptions of false-positive screening results	11
Which clinical, radiological, histological, and molecular parameters are associated with the absence of enhancement of known breast cancers with Contrast Enhanced Digital Mammography (CEDM)?	11
Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis	11
Compliance with multidisciplinary team recommendations and disease outcomes in early breast cancer patients: An analysis of 4501 consecutive patients	11
Mammographic sensitivity as a function of tumor size: A novel estimation based on population-based screening data	11
Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab	11
Impact of radiation dose on complications among women with breast cancer who underwent breast reconstruction and post-mastectomy radiotherapy: A multi-institutional validation study	11
Decisional conflict in breast cancer patients considering immediate breast reconstruction	11
Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study	11
Individualized-thresholding Shear Wave Elastography combined with clinical factors improves specificity in discriminating breast masses	11
Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China	11
Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates	11
Symptoms in long-term breast cancer survivors: A cross-sectional study in primary care	11
The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review	11
Clinicopathological and genomic features of breast mucinous carcinoma	11
Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence	11
CDK 4/6 inhibitors mired in uncertainty in HR positive and HER2 negative early breast cancer	11

Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, India	11
Effects of physical exercise on cognitive function of breast cancer survivors receiving chemotherapy: A systematic review of randomized controlled trials	11
Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia	11
Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data	11
Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost	10
Progression-free survival and quality of life in metastatic breast cancer: The patient perspective	10
Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancer	10
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations	10
A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer	10
Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial	10
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study	10
Trastuzumab deruxtecan versus trastuzumab emtansine for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A cost-effectiveness analysis	10
A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting	10
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world mul	10
Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer	10
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personali	10
The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype	10
Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program	10
Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review	10
Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients	10
Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer	10
Differences in breast cancer risk after benign breast disease by type of screening diagnosis	10
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A pro	9
Rates of margin positive resection with breast conservation for invasive breast cancer using the NCDB	9
Breast magnetic resonance imaging as a problem solving tool in women recalled at biennial screening mammography: A population-based study in the Netherlands	9
The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA	9
Residual breast tissue after robot-assisted nipple sparing mastectomy	9
Treatment of adenoid cystic carcinoma of the breast: Is postoperative radiation getting its due credit?	9
Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study	9
Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21 years	9
Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer	9
Effects of weight reduction on the breast cancer-related lymphedema: A systematic review and meta-analysis	9
Machine-learned identification of psychological subgroups with relation to pain interference in patients after breast cancer treatments	9
Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC)	9
Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival	9
Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot study	9
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study	9
The effect of family history on screening procedures and prognosis in breast cancer patients - Results of a large population-based case-control study	9
Chemotherapy and 21-gene recurrence score testing for older breast cancer patients: A competing-risks analysis	8
A pilot study evaluating the effect of early physical therapy on pain and disabilities after breast cancer surgery: Prospective randomized control trail	8
Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients	8
Polygenic risk scores and breast cancer risk prediction	8
Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients	8
Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study	8
Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis	8
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials	8
Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies	8
Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis	8
Development of novel agents for the treatment of early estrogen receptor positive breast cancer	8
Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer	8
Eligibility of real-world patients with metastatic breast cancer for clinical trials	8
Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer	8
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study	8
HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab	8
Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer	8
Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials	8
Health state utilities for metastatic breast cancer in Taiwan	8
Breast cancer survival in Brazil: How much health care access impact on cancer outcomes?	8
Anthracyclines in the treatment of early breast cancer friend or foe?	8
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China	8
Acinic cell carcinoma of the breast: A comprehensive review	8
Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review	8
Evolution of physical activity and body weight changes in breast cancer survivors five years after diagnosis – VICAN 2 & 5 French national surveys	8
Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy	8
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer	8
The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making	8
Evaluation of 2014 margin guidelines on re-excision and recurrence rates after breast conserving surgery: A multi-institution retrospective study	8
Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer	8
Giving meaning to patient reported outcomes in breast reconstruction after mastectomy – A systematic review of available scores and suggestions for further research	8
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2− advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the	8
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy	8
Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes	8
Towards population-based genetic screenings for breast and ovarian cancer: A comprehensive review from economic evaluations to patient perspectives	7
Locally advanced breast cancer	7
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review	7
A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments	7
How I treat HER2-low advanced breast cancer	7
Patterns of care of breast cancer patients in Morocco – A study of variations in patient profile, tumour characteristics and standard of care over a decade	7
The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin	7
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain	7
Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy	7
Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer	7
Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer	7
Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscope for intraoperative margin assessment - POLARHIS study	7
Are English-language online patient education materials related to breast cancer risk assessment understandable, readable, and actionable?	7
BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications	7
Fertility in Breast Cancer Survivors in the Middle East: A Retrospective Study	7
Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe	7
Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort	7
Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update	7
Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study	7
Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis	7
Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal	7
Is the skin microbiota a modifiable risk factor for breast disease?: A systematic review	7
Older women’s experience with breast cancer treatment: A systematic review of qualitative literature	7